MediPharm Labs

(OTC: MEDIF)
Healthcare  |  Drug Manufacturers—Specialty & Generic
3.08 -0.06 -1.91%
Stock Price | Jan. 17, 2020, 3:56 p.m.
1 Follower
Bid: 3.06
Ask: 3.11
Prev. Close: 3.14
52 Week Low: 1.38
52 Week High: 5.65
PE Ratio: 17.839678
Dividend Yield: 0.0%

Company Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 01/16/20

5 Comments
Yesterday

Premium Toking Tuesday Chat - 01/14/20

2 Comments
2 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/15/20

2 Comments
2 days ago

Premium Cannabis Stocks Review - Weekend Edition 01/13/20

24 Comments
6 days ago

Premium Weekly Review 01/10/20

5 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/08/20

7 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 01/06/20

6 Comments
1 week ago

Premium Weekly Review 01/03/20

1 Comments
2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/03/20

3 Comments
2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 12/30/19

5 Comments
2 weeks ago